Free Trial

CORESTATE Capital (ETR:CCAP) Trading 2.4% Higher - Should You Buy?

CORESTATE Capital logo with Real Estate background

Key Points

  • CORESTATE Capital (ETR:CCAP) saw its stock price increase by 2.4%, closing at €0.35 ($0.41) after a mid-day trading session where 8,354 shares changed hands.
  • The company's market capitalization stands at $57.21 million, with a negative price-to-earnings ratio of -0.02.
  • CORESTATE specializes in real estate investments, focusing on small to medium-sized residential portfolios and expanding its investment strategies to include core-plus and value-add opportunities in Europe.
  • Five stocks we like better than CORESTATE Capital.

CORESTATE Capital Holding S.A. (ETR:CCAP - Get Free Report)'s stock price traded up 2.4% during mid-day trading on Monday . The company traded as high as €0.35 ($0.41) and last traded at €0.35 ($0.41). 8,354 shares changed hands during mid-day trading, The stock had previously closed at €0.34 ($0.40).

CORESTATE Capital Price Performance

The firm's 50-day simple moving average is €0.29 and its 200 day simple moving average is €0.29. The firm has a market capitalization of $57.21 million, a price-to-earnings ratio of -0.02, a P/E/G ratio of -0.01 and a beta of 1.03.

CORESTATE Capital Company Profile

(Get Free Report)

CORESTATE Capital Holding SA is a real estate investment firm specializing in investments in small to medium sized residential portfolios and commercial real estate markets. The firm seeks to invest in an "anti-cyclical" manner in Europe and expand its club-style deals from purely opportunistic to core-plus and value-add investments.

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in CORESTATE Capital Right Now?

Before you consider CORESTATE Capital, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CORESTATE Capital wasn't on the list.

While CORESTATE Capital currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.